The Role of Fluoroquinolones in Tuberculosis Today
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 61 (1) , 9-18
- https://doi.org/10.2165/00003495-200161010-00002
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1998
- Fluoroquinolones: a new treatment for tuberculosis?1998
- The Clinical Use of Fluoroquinolones for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1997
- Pharmacokinetics and Pharmacodynamics of Newer FluoroquinolonesClinical Infectious Diseases, 1996
- gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong KongJournal of Antimicrobial Chemotherapy, 1996
- Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patientsAntimicrobial Agents and Chemotherapy, 1995
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- In VitroActivity of the New Quinolone Lomefloxacin againstMycobacterium tuberculosisAmerican Review of Respiratory Disease, 1992
- A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.1992
- Tissue Penetration of the New Quinolones in HumansClinical Infectious Diseases, 1989